Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Working Capital Changes (2016 - 2025)

Palisade Bio has reported Other Working Capital Changes over the past 16 years, most recently at $127000.0 for Q3 2025.

  • Quarterly Other Working Capital Changes fell 63.61% to $127000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $61000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $61000.0 for FY2025, N/A changed from the prior year.
  • Other Working Capital Changes was $127000.0 for Q3 2025 at Palisade Bio, up from -$34000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $360000.0 in Q4 2022 and troughed at -$472000.0 in Q2 2023.
  • The 5-year median for Other Working Capital Changes is -$34000.0 (2025), against an average of -$30000.0.
  • Year-over-year, Other Working Capital Changes plummeted 863.27% in 2023 and then skyrocketed 452.53% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$39000.0 in 2021, then skyrocketed by 1023.08% to $360000.0 in 2022, then plummeted by 130.28% to -$109000.0 in 2023, then surged by 420.18% to $349000.0 in 2024, then tumbled by 63.61% to $127000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Working Capital Changes are $127000.0 (Q3 2025), -$34000.0 (Q2 2025), and -$32000.0 (Q1 2025).